Lisata Therapeutics Financial Overview
Lisata Therapeutics's market cap is currently $18.26M. The company's EPS TTM is $-0.49; its P/E ratio is -0.97; Lisata Therapeutics is scheduled to report earnings on November 6, 2025, and the estimated EPS forecast is $-0.51. See an overview of income statement, balance sheet, and cash flow financials.
